Methods for prediction and prognosis of cancer, and monitoring cancer therapy

Details for Australian Patent Application No. 2006315592 (hide)

Owner Bayer Pharmaceuticals Corporation

Inventors Wilhelm, Scott; Elting, James

Agent Davies Collison Cave

Pub. Number AU-A-2006315592

PCT Pub. Number WO2007/059094

Priority 60/735,854 14.11.05 US

Filing date 14 November 2006

Wipo publication date 24 May 2007

International Classifications

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

12 June 2008 PCT application entered the National Phase

  PCT publication WO2007/059094 Priority application(s): WO2007/059094

21 August 2008 Alteration of Name

  The name of the applicant has been altered to Bayer Healthcare LLC

18 November 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006315593-System and method for rapid input of data

2006315580-Method of treating ovarian and renal cancer using antibodies against T cell immunoglobulin domain and mucin domain 1 (TIM-1) antigen